ALX Oncology Exchanges 13,353,384 Common Shares for Pre-Funded Warrants
Bitget2026/10/15 20:56- ALX Oncology agreed October 14, 2026, to exchange 13,353,384 common shares for pre-funded warrants covering the same number of shares.
- Blackstone-affiliated funds account for 12,885,891 shares; RA Capital Healthcare Fund, 213,667; venBio Global Strategic Fund, 253,826.
- The unregistered issuance relies on a Section 3(a)(9) exemption, with settlement expected on or about October 15, 2026.
- Warrants carry a $0.001-per-share exercise price, exercisable from issuance until fully exercised through cash payment or cashless exercise.
- Exercise is subject to 4.99% or 9.99% ownership caps; holders may raise caps to 19.99%, effective 61 days following notice.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ—US Stock Market Updates: CoreWeave, Travelers, Tesla

Bank of America Hartnett: "Still inclined toward risk aversion" in the coming weeks, as US Treasuries set a four-year record for longest inflow streak
U.S. equity funds attracted $39 billion in inflows in a single week, pushing the annualized scale toward a historic high, while U.S. Treasuries also saw capital inflows for 16 consecutive weeks. However, Bank of America strategist Hartnett warns that due to rising real yields, the performance of AI and banking stocks, and the volatility of the midterm elections, there is still a preference for risk aversion in the coming weeks.